Alertgy has been featured in a recent article in The Silicon Review, one of the world’s most trusted online and print community for business technology professionals. Our CEO, Marc Rippen, was interviewed on a range of topics from the start of the company to Alertgy’s vision for the future. Read the entire article below!
After the MEMS MSEC 2018 Technology showcase, Alertgy has been featured in the IEEE Spectrum Blog. Tekla S. Perry wrote about Alertgy saying, “The other standout in the showcase: Alertgy’s noninvasive method of monitoring changes in blood glucose.”
To read the full article, follow this link : https://spectrum.ieee.org/view-from-the-valley/consumer-electronics/portable-devices/sensorladen-gadgets-track-package-abuse-and-blood-sugar-changes
Alertgy has won the MSEC 2018 Technology showcase in Napa, California. The Technology Showcase event highlights state of the art, new sensor technology. This year Alertgy competed against N5 Sensors, NXP, Scorched Ice, and Sportfitz. We were able to present our non-invasive continuous glucometer technology to over 100 attendees and members of the press. Alertgy is extremely proud to have won this event, further establishing ourselves as a leader and innovator in the diabetes space.
“Fasting can reverse type 2 diabetes, a team of scientists behind a small study have claimed.
For their preliminary study, researchers asked three patients with type 2 diabetes to follow intermittent fasting programs and found they were able to safely stop using insulin to control their blood sugar levels.
Diabetes is a major health issue in the U.S. closely linked to the obesity epidemic. Around 30.3 million people in the U.S. have the condition according to the latest figures from 2015: including 7.2million who are undiagnosed, according to the American Diabetes Association.
Most people have type 2 diabetes, where the body develops insulin resistance causing blood glucose levels to shift out of the normal range.”
Read the whole story here : https://www.newsweek.com/type-2-diabetes-treatment-intermittent-fasting-reverses-disease-1159579
Alertgy will be heading to Napa, California on October 28th for the MEMS and Sensors Executive Congress. We will be competing in the technology showcase, an opportunity to highlight our sensor technology to others in the technology community and create great connections. This is another amazing opportunity for Alertgy to continue to reach out and gain notoriety outside of Florida. Follow along with us on Facebook and Twitter as we will be providing updates and pictures throughout MSEC 2018!
Innovate Celebrate has selected Alertgy as a top 100 startup for 2018. We will be participating in the “Startup Of the Year” competition from October 15th-17th, in Boston. This competition also features the Peoples Choice Award, which will be decided by a one vote per person system open to the public. Follow this link and vote for Alertgy!
One of our team members had the opportunity to travel to Cadillac Ranch, a free of charge park just southwest of Amarillo, Texas. This public art work was opened in 1974 and consists of 10 Cadillac cars buried face down in the dirt. Visitors to the park are encouraged to write or draw on the cars, something an estimated one million people do per year. John Hubert, a senior engineer at Alertgy, was able to leave the company’s mark on this farmland 1500 miles from Melbourne. Anyone who passes through this area should check out Cadillac Ranch, and take a look to see if Alertgy is still represented!
You can learn more about his area here https://www.theroute-66.com/cadillac-ranch.html
Alertgy has been named as a finalist for the Health 2.0 VentureConnect event on Sunday, September 16th in Santa Clara, California. After a long process with multiple cuts, we have made it to the finale. This event will put Alertgy front and center for various venture capitalists and other investors. A 4 panel judge will select 2 winners after the pitch competition who will be named the new “Startup Champions”. The judges include Terri Mead, Shubhra Jain, John Rosano, and Jody Holtzman.
Alertgy is very pleased and honored to announce that Dr. John Burd has joined its board of directors. Dr. Burd brings to Alertgy over 30 years of experience in the continuous glucose monitoring industry. He is a true pioneer in his field having founded DexCom. At DexCom he directed the company’s work to develop, manufacture and market the first long-term implantable glucose sensor for people with diabetes. DexCom has a present market capitalization of more than $10 billion. After leaving DexCom he continued in his work as CEO of Oculir, MiraMedica, LXN, and continuous his quest to bring technologies to market to fulfill critical yet unmet needs of diabetics. After visiting Alertgy’s R&D center in Melbourne, Florida and having the Alertgy device tested on him he was amazed to see for himself that our technology will provide diabetics a solution to meet their most critical need: an affordable, easy to use, truly non invasive continuous blood glucose monitor and alert system. He has become Alertgy’s strongest advocate. Dr. Burd has authored and co-authored numerous articles and his work in the medical and biotechnology field has led to the filing and ownership of twenty-three patents and the development of many innovative medical products. He graduated from Purdue University with a B.S. in Biochemistry, and earned an M.S. and Ph.D., also in Biochemistry, from the University of Wisconsin.
Medtech Outlook has selected Alertgy as a top 10 diabetes care solution provider, to be showcased in the October 2018 diabetes care edition. After a rigorous evaluation process competing against numerous other companies, Alertgy was one of 10 selected for this honor. The article will contain a one-page paper touching on various subjects such as our unique customer centered solutions, immense market possibilities, and our vision for the future. This opportunity will allow Alertgy to come face-to-face with the over 100,000 print and digital MedTech Outlook subscribers, giving us the ability to exhibit our company to tens of thousands of both healthcare professionals and diabetics around the world. With this article, Alertgy will further build meaningful relationships with professionals in the industry, while simultaneously broadening our name recognition with potential strategic partners and future consumers.